Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Visit the company website

 

Bullboard - Investor Discussion Forum Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX... see more

TSXV:VM - Post Discussion

Voyageur Pharmaceuticals Ltd > $1.9M sales contract
View:
Post by biggdogg on May 28, 2024 10:10am

$1.9M sales contract

Great News, ................. And no rise in share price? Two small markets in Latin America? This shows they are going to be announcing millions of $ of more contracts soon, and that they have a sound business. Whats up?
Comment by whitenorth72 on May 28, 2024 10:19am
It's a massive milestone and it sounds like they are in talks with European and Asian markets as well. https://youtu.be/xnC01i2jPms
Comment by postie1 on May 28, 2024 3:24pm
One would think this should be the start of attaining credibility for getting financing . That is just 1 product in 2 latin american countries and 4 more products to go,. Big plus that the distributer is going to pay for approval  as that saves VM money that is scarce right now.  Just cannot fathom anybody willing to sell at this price with the sales in the big markets that should come ...more  
Comment by WarrantOfficer on May 28, 2024 11:48am
Execution phase......it is a long awaited and highly anticipated beginning. 
Comment by lscfa on May 28, 2024 8:56pm
Spin 101: - do not say how long it will take partner to get approvals (12 -18 months?).  - disclose the 3 yr contract amount (with out mentioning that most of it will be backended?) and hope readers assume the amount is received equally over 3 years.   mgmt, get on with selling product in Canada now.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.VM

follow v.vm on


Voyageur Pharmaceuticals Deck 2024..

The Watchlist

Voyageur Pharmaceuticals | The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

COMPELLING
VALUE PROPOSITION

  • Only pharmaceutical company in the world that owns long-term supply of barium and iodine
  • Natural barium and iodine resources meet increasingly limited global supply and risk
  • Multi-billion-dollar global market for contrast media
  • Poised to obtain significant market share by offering high-quality, lower-cost products
  • Favorable regulatory pathway allows rapid commercialization
  • Highly experienced team has positioned the company for profitable commercial success

Contact Us

Brent Willis, CEO
Brent@Vpharma.ca

Address:
Suite 1600 Dome Tower, 333 7th Avenue S.W.
Calgary, Alberta
T2P 2Z1